Legal status · Canada
Is Adropin legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Adropin is not an approved medicine in Canada; its classification is "Not a medicine; endogenous signalling molecule". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 1 human study is cited on its profile.
Adropin in Canada at a glance
| Classification | Not a medicine; endogenous signalling molecule |
|---|---|
| Note | Research analyte, not a medicine. |
| Health Canada approval status | Not approved by Health Canada |
| Human studies cited | 1 of 3 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Adropin profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
No product containing Adropin is approved by Health Canada for any use in Canada, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Canada. This page is general information, not legal advice.
What Adropin is
A secreted peptide whose blood level falls with obesity and age in humans. Every human study is a measurement, not a treatment: no one has given adropin to a person, and the cognitive benefit that gets quoted was in aging mice.
Adropin is encoded by ENHO and circulates at low nanogram per millilitre concentrations. It came out of mouse work suggesting a peptide required for metabolic homeostasis and for preventing obesity-associated insulin resistance.
Mechanism: A secreted peptide that in animal work influences fuel selection, favouring glucose over fatty acid oxidation in muscle, and improves insulin sensitivity and endothelial function. Receptor biology is unsettled: GPR19 has been proposed and is disputed, and a 2025 review frames adropin as a cardio-metabolic hormone in the periphery and a neurohormone in the brain, which is a way of saying the mechanism differs by tissue and is not pinned down in either.
Regulatory history: Not a drug. Adropin is an endogenous peptide measured in research studies. No adropin product is approved anywhere and no interventional human trial has been registered.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Adropin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Adropin in other countries
United States
Not approvedNot a medicine; endogenous signalling molecule
Is Adropin legal in the United States?United Kingdom
Not approvedNot a medicine; endogenous signalling molecule
Is Adropin legal in the United Kingdom?Australia
Not approvedNot a medicine; endogenous signalling molecule
Is Adropin legal in Australia?Frequently asked questions
Is Adropin legal in Canada?
No. Adropin is not an approved medicine in Canada; its classification is "Not a medicine; endogenous signalling molecule". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 1 human study is cited on its profile. Note: Research analyte, not a medicine.
Can I buy Adropin in Canada?
No approved product exists to buy. In Canada Adropin is classified as "Not a medicine; endogenous signalling molecule", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: Research analyte, not a medicine.
Is Adropin Health Canada approved?
No. In Canada Adropin is classified as "Not a medicine; endogenous signalling molecule", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Not a drug. Adropin is an endogenous peptide measured in research studies. No adropin product is approved anywhere and no interventional human trial has been registered.. On the evidence, 1 human study is cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Adropin live on its compound profile.
Adropin profileThis page is general information about the regulatory status of Adropin in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.